Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dipeptidyl peptidase 8 (DPP8) is an intracellular serine protease that cleaves dipeptides from the N-terminus of polypeptides, specifically at proline or alanine residues. It belongs to the peptidase S9B family and shares structural and functional similarities with DPP4. DPP8 is ubiquitously expressed and plays roles in protein maturation, degradation, and immune regulation. Inhibition of DPP8, particularly in conjunction with its homolog DPP9, can activate inflammasomes and induce pyroptosis, highlighting potential therapeutic implications and safety concerns.
Inhibition of DPP8 and DPP9 leads to inflammasome activation via NLRBP1/CARD8 pathways, resulting in pyroptosis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dipeptidyl Peptidase 8 (DPP8).